MedTrace Logo

Evaluation of Diaphragm Movement After an Interscalene Block

NCT03636542 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-11-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the movement of the diaphragm after an interscalene block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine. This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using liposome bupivacaine in an interscalene block, using ultrasound.

Conditions

  • Phrenic Nerve Paralysis

Interventions

DRUG

liposomal bupivacaine

Experimental

DRUG

bupivacaine

Active comparator

Sponsors & Collaborators

Principal Investigators

  • Jason habeck, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-06-03
Completion
2020-06-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636542 on ClinicalTrials.gov